BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23879574)

  • 1. Prognostic impact of LIM domain only 2 (LMO2) in chronic myelogenous leukaemia.
    Atay MH; Ozatli D; Kelkitli E; Yildiz L; Turgut M; Guler N; Toptas T
    Histopathology; 2013 Aug; 63(2):293-4. PubMed ID: 23879574
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody.
    Agostinelli C; Paterson JC; Gupta R; Righi S; Sandri F; Piccaluga PP; Bacci F; Sabattini E; Pileri SA; Marafioti T
    Histopathology; 2012 Jul; 61(1):33-46. PubMed ID: 22394247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and significance of HGAL and LMO2 in follicular lymphoma].
    Zhang F; Luo D; Luo X; Chen Y; Xu J; Chen J; Zhuang H; Liu Y
    Zhonghua Bing Li Xue Za Zhi; 2016 Feb; 45(2):83-5. PubMed ID: 26879427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms.
    Menter T; Gasser A; Juskevicius D; Dirnhofer S; Tzankov A
    Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):491-8. PubMed ID: 25203428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.
    Cerhan JR; Natkunam Y; Morton LM; Maurer MJ; Asmann Y; Habermann TM; Vasef MA; Cozen W; Lynch CF; Allmer C; Slager SL; Lossos IS; Chanock SJ; Rothman N; Hartge P; Dogan A; Wang SS
    Leuk Lymphoma; 2012 Jun; 53(6):1105-12. PubMed ID: 22066713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype.
    Patel JL; Pournazari P; Haggstrom SJ; Kosari F; Shabani-Rad MT; Natkunam Y; Mansoor A
    Histopathology; 2014 Jan; 64(2):226-33. PubMed ID: 24330148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of IgM, CD21, HGAL and LMO2 in the diagnosis of pediatric follicular lymphoma.
    Karnik T; Ozawa MG; Lefterova M; Luna-Fineman S; Alvarez E; Link M; Zehnder JL; Arber DA; Ohgami RS
    Hum Pathol; 2015 Apr; 46(4):629-33. PubMed ID: 25701230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma.
    Jevremovic D; Roden AC; Ketterling RP; Kurtin PJ; McPhail ED
    Am J Clin Pathol; 2016 Feb; 145(2):180-90. PubMed ID: 26796495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Lhx2 suppresses proliferation of human T cell acute lymphoblastic leukemia-derived cells, partly by reducing LMO2 protein levels.
    Miyashita K; Kitajima K; Goyama S; Kitamura T; Hara T
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2310-2316. PubMed ID: 29278703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients.
    Culpin RE; Sieniawski M; Angus B; Menon GK; Proctor SJ; Milne P; McCabe K; Mainou-Fowler T
    Histopathology; 2013 Dec; 63(6):788-801. PubMed ID: 24117687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma.
    Lossos C; Bayraktar S; Weinzierl E; Younes SF; Hosein PJ; Tibshirani RJ; Sutton Posthumus J; DeAngelis LM; Raizer J; Schiff D; Abrey L; Natkunam Y; Lossos IS
    Br J Haematol; 2014 Jun; 165(5):640-8. PubMed ID: 24571259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model.
    Pais H; Ruggero K; Zhang J; Al-Assar O; Bery N; Bhuller R; Weston V; Kearns PR; Mecucci C; Miller A; Rabbitts TH
    Sci Rep; 2019 Apr; 9(1):5760. PubMed ID: 30962539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDB1 Enforces Stability on Direct and Indirect Oncoprotein Partners in Leukemia.
    Layer JH; Christy M; Placek L; Unutmaz D; Guo Y; Davé UP
    Mol Cell Biol; 2020 May; 40(12):. PubMed ID: 32229578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis.
    Morishima T; Krahl AC; Nasri M; Xu Y; Aghaallaei N; Findik B; Klimiankou M; Ritter M; Hartmann MD; Gloeckner CJ; Stefanczyk S; Lindner C; Oswald B; Bernhard R; Hähnel K; Hermanutz-Klein U; Ebinger M; Handgretinger R; Casadei N; Welte K; Andre M; Müller P; Bajoghli B; Skokowa J
    Blood; 2019 Oct; 134(14):1159-1175. PubMed ID: 31366618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer.
    Liu Y; Huang D; Wang Z; Wu C; Zhang Z; Wang D; Li Z; Zhu T; Yang S; Sun W
    Sci Rep; 2016 Oct; 6():36050. PubMed ID: 27779255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of microRNA-223 in lymphocytic leukemia cells and its action mechanism].
    Nan Z; Liang Y; Fu R; Liu H; Ruan EB; Wang XM; Wang GJ; Qu W; Liu H; Wu YH; Song J; Xing LM; Guan J; Li LJ; Wang HQ; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):556-61. PubMed ID: 23815897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
    Layer JH; Alford CE; McDonald WH; Davé UP
    Mol Cell Biol; 2016 Feb; 36(3):488-506. PubMed ID: 26598604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of E-cadherin promoter activity by LMO2 impact on the progression and metastasis of prostate cancer].
    Peng X; Ye Z; Gao Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):385-9. PubMed ID: 24386807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of clinical characteristics and immunophenotypic biomarkers in 115 patients with primary central nervous system lymphoma.
    Chen BB; Xu XP; Shen L; Han TJ; Lin ZG; Chen Z; Kang H; Huang B; Lin GW
    Chin Med J (Engl); 2013 Feb; 126(3):482-7. PubMed ID: 23422111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIM domain only 2 induces glioma invasion via cytosolic p27(KIP1).
    Park CG; Sohn YW; Kim EJ; Kim SH; Kim SC; Kim H
    Tumour Biol; 2016 Feb; 37(2):2473-80. PubMed ID: 26383528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.